Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Dose the Clinical Characteristics of Patients with Anxiety due to Hyperthyroidism Differ from Patients with Generalized Anxiety Disorder? A Comparative Study

Arash Mowla 1 , * , Mohammad Reza Kalantarhormozi 2 and Samane Khazraee 1
Authors Information
1 Department of Psychiatry, Substance Abuse and Mental Health Research Center, Hafez Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Endocrinology, Bushehr University of Medical Sciences, Bushehr, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: March 2017, 11 (1); e4812
  • Published Online: October 17, 2016
  • Article Type: Brief Report
  • Received: November 24, 2015
  • Revised: March 4, 2016
  • Accepted: October 1, 2016
  • DOI: 10.5812/ijpbs.4812

To Cite: Mowla A, Kalantarhormozi M R, Khazraee S. Dose the Clinical Characteristics of Patients with Anxiety due to Hyperthyroidism Differ from Patients with Generalized Anxiety Disorder? A Comparative Study, Iran J Psychiatry Behav Sci. 2017 ; 11(1):e4812. doi: 10.5812/ijpbs.4812.

Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Materials and Methods
3. Results
4. Discussion
  • 1. Tyrer P, Baldwin D. Generalised anxiety disorder. Lancet. 2006; 368(9553): 2156-66[DOI][PubMed]
  • 2. Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking M, Andersson G. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev. 2014; 34(2): 130-40[DOI][PubMed]
  • 3. Dezonne RS, Stipursky J, Araujo AP, Nones J, Pavao MS, Porcionatto M, et al. Thyroid hormone treated astrocytes induce maturation of cerebral cortical neurons through modulation of proteoglycan levels. Front Cell Neurosci. 2013; 7: 125
  • 4. Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Phys. 2016; 93(5): 363-70
  • 5. Sala-Roca J, Marti-Carbonell MA, Garau A, Darbra S, Balada F. Effects of dysthyroidism in plus maze and social interaction tests. Pharmacol Biochem Behav. 2002; 72(3): 643-50[PubMed]
  • 6. Feldman AZ, Shrestha RT, Hennessey JV. Neuropsychiatric manifestations of thyroid disease. Endocrinol Metab Clin North Am. 2013; 42(3): 453-76[DOI][PubMed]
  • 7. Bunevicius R, Prange AJ. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options. CNS Drugs. 2006; 20(11): 897-909[PubMed]
  • 8. Ittermann T, Volzke H, Baumeister SE, Appel K, Grabe HJ. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol. 2015; 50(9): 1417-25[DOI][PubMed]
  • 9. Chattopadhyay C, Chakrabarti N, Ghosh S. An assessment of psychiatric disturbances in Graves disease in a medical college in eastern India. Niger J Clin Pract. 2012; 15(3): 276-9[DOI][PubMed]
  • 10. First MB, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV (SCID-I) Clinical Version. 1995;
  • 11. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1): 50-5
  • 12. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001; 13(4): 166-78[PubMed]
  • 13. Clark DB, Donovan JE. Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescent sample. J Am Acad Child Adolesc Psychiatry. 1994; 33(3): 354-60[DOI][PubMed]
  • 14. Rodewig K. [Psychosomatic aspects of hyperthyroidism with special reference to Basedow's disease. An overview]. Psychother Psychosom Med Psychol. 1993; 43(8): 271-7[PubMed]
  • 15. Whybrow PC, Prange AJ. A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to affective illness. Arch Gen Psychiatry. 1981; 38(1): 106-13[PubMed]
  • 16. Iacovides A, Fountoulakis KN, Grammaticos P, Ierodiakonou C. Difference in symptom profile between generalized anxiety disorder and anxiety secondary to hyperthyroidism. Int J Psychiatry Med. 2000; 30(1): 71-81[PubMed]
  • 17. Placidi GPA, Boldrini M, Patronelli A, Fiore E, Chiovato L, Perugi G, et al. Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology. 1998; 38(4): 222-5
  • 18. Lader MH. Assessment methods and the differential diagnosis of anxiety. J Clin Psychopharmacol. 1981; 1(6): 342-9[PubMed]
  • 19. Dietch JT. Diagnosis of organic anxiety disorders. Psychosomatics. 1981; 22(8): 661-9
  • 20. Artunkal B, Togrol B. Brain Thyroid Relationships. 1998; 55: 543-53
  • 21. Wallace JE, MacCrimmon DJ, Goldberg WM. Acute hyperthyroidism: cognitive and emotional correlates. J Abnorm Psychol. 1980; 89(4): 519-27[PubMed]
  • 22. de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol. 2011; 165(4): 545-54[DOI][PubMed]
  • 23. Gittoes NJ, Franklyn JA. Current treatment guidelines. Drugs. 1998; 55(4): 543-53
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments